Felix Blei

Dr.

CEO and Scientific director , miraculix and "ALIVE" , Implementation of toxicological substance analysis in the "ALIVE" project (analysis-based intervention), which is the first mobile drug checking in Germany at parties and festivals in the state of Thuringia. The development of the world's first quantitative rapid tests (QTests) for psychoactive substances is continuing. Currently, there are QTests for the substances LSD, MDMA, THC/CBD, and Psilocybin. The focus here is on the further development and implementation of new quantitative quick tests.

Jena, germany

About

Dr. Felix Blei is a pharmaceutical microbiologist and expert in the analysis of natural compounds. He developed the first quantitative rapid tests for active substances such as psilocybin, LSD, MDMA and various amphetamines. He is the founder and scientific director of miraculix, which is performing the first mobile drug checking model project in Germany in a cooperation with the addiction support in Thuringia. With the ALIVE project, the analysis-based intervention, consumers in Thuringia have been protected from dangerous overdoses, misdeclaration or admixtures for the first time and with great success since last year, and the associated education and counseling is carried out.

QTests by miraculix - the first quantitative quick tests for psychoactive substances

The correct dosage is what miraculix is concerned with: for this purpose, we have developed at the university simple rapid concentration tests and taken over the analysis in the first German mobile drug checking project ALIVE. With our tests, users also have the possibility to reliably and quickly analyze the composition and concentration of their psychoactive substances themselves. By means of the newly developed rapid test procedures, it is even possible for mobile for the first time to make statements about the quality and quantity of an active substance within a few minutes without any significant effort and without any expert knowledge. In the first step, the active ingredient is extracted from the sample and detected and quantified in the second step.